Yi‐Cheng Shen
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions 4
- Lung Cancer Research Studies 3
- Cancer Research top 10%
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 4
- Toxicology top 10%
-
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 3
-
- Nosocomial Infections in ICU 3
-
- Privacy-Preserving Technologies in Data 3
-
- IoT and Edge/Fog Computing 2
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Yi‐Cheng Shen
28 papers receiving 892 citations
Peers
Comparison fields: 5 of 109
- Oncology 318
- Cancer Research 173
- Molecular Medicine 52
- Applied Microbiology and Biotechnology 18
- Toxicology 29
Countries citing papers authored by Yi‐Cheng Shen
This map shows the geographic impact of Yi‐Cheng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Cheng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Cheng Shen more than expected).
Fields of papers citing papers by Yi‐Cheng Shen
This network shows the impact of papers produced by Yi‐Cheng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Cheng Shen. The network helps show where Yi‐Cheng Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi‐Cheng Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 14 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 9 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 25 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 17 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 5 | |
| 17 | 2019 | 0 | |
| 18 | 2018 | 60 | |
| 19 | 2017 | 280 | |
| 20 | 2014 | 233 |
About Yi‐Cheng Shen
Yi‐Cheng Shen is a scholar working on Molecular Medicine, Critical Care and Intensive Care Medicine and Applied Microbiology and Biotechnology, having authored 30 papers that have together received 897 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Antibiotic Resistance in Bacteria (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Nosocomial Infections in ICU (3 papers), Lung Cancer Research Studies (3 papers), Privacy-Preserving Technologies in Data (3 papers) and IoT and Edge/Fog Computing (2 papers). The work is most often cited by research in Oncology (318 citations), Cancer Research (173 citations) and Molecular Medicine (52 citations). Yi‐Cheng Shen has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Qiang Shen, Yu Wang, Sinan Wang, Xuan Zhou, Jia Zhou, Ailian Xiong, Zhengduo Yang, Chih‐Yen Tu, Lewis Tseng and Chih‐Hsin Tang. Their work appears in journals such as Neurology, Scientific Reports and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.